BOI:EPA
Boiron SA
€ १८.४०
arrow_upward
+१.३८%(+०.२५) 1D
अक्टोबर २०, ०९:३८:४९ GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
€ १८.१५
High
€ १८.४०
Low
€ १८.१०
Mkt. cap
३२.२८ करोड
Avg. vol.
५.५० हजार
Volume
६७०.००
P/E ratio
१२.२०
52-wk high
€ ३२.००
52-wk low
€ १६.९०
EPS
€ १.५१
Shares outstanding
१.७५ करोड
No. of employees
३ हजार
Open
€ १८.१५
High
€ १८.४०
Low
€ १८.१०
Mkt. cap
३२.२८ करोड
Avg. vol.
५.५० हजार
Volume
६७०.००
P/E ratio
१२.२०
52-wk high
€ ३२.००
52-wk low
€ १६.९०
EPS
€ १.५१
Shares outstanding
१.७५ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
The Motley Fool
·
४ मिनेट पहिले
IVV vs. SPY: Which S&P 500 ETF Is the Better Buy for Long-Term Investors?
Yahoo Finance
·
३४ मिनेट पहिले
Should You Wait Until After the Midterm Elections to Buy the S&P 500?
The Arkansas Democrat-Gazette
·
३९ मिनेट पहिले
AI stocks recover some losses; rest of market shaky
CNBC
·
६ घण्टा पहिले
CNBC Daily Open: Tech investors buy the dip — but debt remains a concern
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA